Ginekologija - sve o tome
Moderator: anex
-
macy_A
- Posts: 46
- Joined: 06/07/2009 20:32
#376 Re: Ginekologija i vagine....
hvala vam puno, objema, evo zvala sam dr. i dobila termin za sutra..nadam se da nije ništa ozbiljno...
-
BIONA
- Posts: 1340
- Joined: 02/09/2009 21:53
- Contact:
#377 Re: Ginekologija i vagine....
Sretno pa javi sta je bilo... a taj caj poznatiji kao kunica ili hajducka trava se moze kupiti i u apotekama,i u prodavnicama.Jako je ljekovit pa se najvise preporucuje zenama koje imaju bilo kakvih zenskih problema.Treba ga duze piti po jednu solju dnevno.Ne skodi bilo kakvoj propisanoj terapiji.

- mondo bizarro
- Posts: 62826
- Joined: 16/07/2009 00:24
- Location: sa yossarianom na pianosi
#378 Re: Ginekologija i vagine....
za te upale su tđ. dobri čajevi od: peršuna, macine trave=kediot, kukuruzne svile i naravno već spomenuta kunica=hajdučka trava, a ako nema toga, u svakoj samoposluzi ima uvin čaj 
- dzidzana
- Posts: 17
- Joined: 03/10/2009 14:09
#379 Re: Ginekologija i vagine....
Jedina infekcija koja ima neugodan miris je Trihomonas vaginalis. Mozes je sanirati kratko sa Betadine vaginaletama, al ti se i hairlija mora lijeciti. BTW ja sam to govno imala i dali mi pogresnu terapiju tako da je preslo u hronicno... Nakalemi se za 10 dana kandida i onda za nju ti je potrebno 6 mjeseci lijecenja... Najbolje se najedi bijelog luka i kupi ove betadine. nakon svakog kekksa po jednu gurni. OBAVEZNO ginekologu... Obavezno oboje terapiju trosite... U protivnom ce ici tamo-vamo...macy_A wrote:ma najsličniji je bijelom pranju, zapravu iscjedku koji se javlja prilikom ovulacije, a to je i taj period otprilike...
i ima jako neugodan miris....
evo upravo sam pošla da zovem polikliniku da si dogovorim termin....
hvala u svakom slučaju....gdje mogu nabaviti ovaj pomenuti čaj??? u apoteci???
A sto se tice Nejre Pasic... Rekla mi je da je to od Allaha sto smo bolesni.. Pricala kako je haram imati sex prije braka i tako to...
-
macy_A
- Posts: 46
- Joined: 06/07/2009 20:32
#380 Re: Ginekologija i vagine....
ma nije kod mene ništa strašno, bila sam ja kod dr. Amre u Clarusu,imam malo upale i malo bakterija, dobila sam vaginalete Polygynax i kremu Travocort za vanjsku upotrebu, preporučila mi je i neki gel za pranje intimnih dijelova, kojeg nije bilo u apoteci , a košta oko 16 KM....
ona je po kliničkoj slici mislil da je Candida ali je radila analizu sekreta i sve je bilo ok...
ipak hvala za savjete...
)
ona je po kliničkoj slici mislil da je Candida ali je radila analizu sekreta i sve je bilo ok...
ipak hvala za savjete...
-
dia81
- Posts: 445
- Joined: 31/03/2007 20:51
- Location: sarajevo
#381 Re: Ginekologija i vagine....
ja sam imala candidu i uzimala polyganax i evo vec godinu i nesto sam super...pored toga uzimaj dosta probiotika, mozes i lactogyn...meni je pomoglo
-
Astarot
- Posts: 21
- Joined: 16/10/2009 10:44
#382 Re: Ginekologija i vagine....
Jako korisna stranica koju preporucujem djevojkama, zenama i majkama da pogledaju, i razmisle o HPV njihovim sexualnim apetitima i redovitim pregledima koji kao sto kazu ce biti obavezni iduce godine.Donosi se zakonska regulativa da ce svaka zena u dobi od 25-66g cinimi se dobiti poziv na papa pregled.
Vakcine kod nas jesu registrirane, Cervarix 16,18, 31, 45... i Gardasil 6,11,16,18.Imajte u vidu da jos nisu obavezne ali se mogu nabaviti u svakoj bolje oprijemljenoj apoteci...Naravno mislim da je i o tome dobro popricati sa ginekologom, pedijatrom ili ko je vec odgovoran za vakcinaciju...Ljudi to je sasvim normalno, evo svi smo se vakcinisali protiv raznih bolescija,,,nasa djeca takodje...Prevencija je majka svih medicina
Razmislite...
http://www.cervicalcancerinfo.co.uk/index.asp
Vakcine kod nas jesu registrirane, Cervarix 16,18, 31, 45... i Gardasil 6,11,16,18.Imajte u vidu da jos nisu obavezne ali se mogu nabaviti u svakoj bolje oprijemljenoj apoteci...Naravno mislim da je i o tome dobro popricati sa ginekologom, pedijatrom ili ko je vec odgovoran za vakcinaciju...Ljudi to je sasvim normalno, evo svi smo se vakcinisali protiv raznih bolescija,,,nasa djeca takodje...Prevencija je majka svih medicina
http://www.cervicalcancerinfo.co.uk/index.asp
-
Astarot
- Posts: 21
- Joined: 16/10/2009 10:44
- Loulou
- Posts: 3017
- Joined: 16/04/2008 15:18
#384 Re: Ginekologija i vagine....
Ovi pozivi na godišnji ginekološki pregled su odavno (dobro, možda ne baš odavno) praksa u UK, koliko znam. Tako su mi tamošnje cure rekle. A ako se ne odazoveš, valjda se plaćaju kazne, kako li...Astarot wrote:Jako korisna stranica koju preporucujem djevojkama, zenama i majkama da pogledaju, i razmisle o HPV njihovim sexualnim apetitima i redovitim pregledima koji kao sto kazu ce biti obavezni iduce godine.Donosi se zakonska regulativa da ce svaka zena u dobi od 25-66g cinimi se dobiti poziv na papa pregled.
http://www.cervicalcancerinfo.co.uk/index.asp
Nisam čula da se to kod nas uvodi. Od kada? Mislim da je to odlična stvar da se potakne one koje još uvijek "mistificiraju" te preglede.
U nekim kantonima postoje i javni pozivi (zalijepljeni na oglasnim tablama Domova zdravlja, bolnica...) ženama da se obavezno javljaju na godišnje preglede jer je ustanovljen nevjerovatan porast malignih oboljenja ženskih reproduktivnih organa.
-
Astarot
- Posts: 21
- Joined: 16/10/2009 10:44
#385 Re: Ginekologija i vagine....
Da, u sredjenim zemljama je skroz drugacije.Nasa okolina tacnije u Srbiji su usvojili takav zakon, jer po broju incidenci smrtnosti od CeCa Srbija je No1, pa Albanija i Bosna. Da, ukoliko se ne odazoves u nekom odredjenom periodu, slijedi ti kazna.E sad kako ce to u nas biti-Ptice znaju.Bitno je da se odazove, jer bez pregleda nema nista. a licno znam i nagledao sam se preparata i operacija djevojaka koje su bile u kasnoj fazi raka-25, 26 godina...Katastrofa.
U UK je druga situacija-oni su pokrenuli kampanju prevencije-vakcinacija djevojcica 12-13 god i 17-18 god. a rezultati ce se vidjeti tek za 10-15 god. Tako to ide...Da Bog da da i nama drzava obezbijedi takvo sta ;(
U UK je druga situacija-oni su pokrenuli kampanju prevencije-vakcinacija djevojcica 12-13 god i 17-18 god. a rezultati ce se vidjeti tek za 10-15 god. Tako to ide...Da Bog da da i nama drzava obezbijedi takvo sta ;(
-
Pera Trta
- Posts: 5420
- Joined: 06/02/2009 00:20
- Location: Zabela kod Požarevca,rodnog mesta predsednika,njegova je zadužbina i njegova verna slika.
#386 Re: Ginekologija i vagine....
Ovo je zaista jedini način da screening na cervikalni karcinom i borba s njim imaju neki smisao. Sve dok je to na dobrovoljnoj bazi, ništa od toga.Astarot wrote:Da, u sredjenim zemljama je skroz drugacije.Nasa okolina tacnije u Srbiji su usvojili takav zakon, jer po broju incidenci smrtnosti od CeCa Srbija je No1, pa Albanija i Bosna. Da, ukoliko se ne odazoves u nekom odredjenom periodu, slijedi ti kazna.E sad kako ce to u nas biti-Ptice znaju.Bitno je da se odazove, jer bez pregleda nema nista. a licno znam i nagledao sam se preparata i operacija djevojaka koje su bile u kasnoj fazi raka-25, 26 godina...Katastrofa.
U UK je druga situacija-oni su pokrenuli kampanju prevencije-vakcinacija djevojcica 12-13 god i 17-18 god. a rezultati ce se vidjeti tek za 10-15 god. Tako to ide...Da Bog da da i nama drzava obezbijedi takvo sta ;(
-
vkvmajstor
- Posts: 14
- Joined: 16/04/2008 02:03
- semmy
- Posts: 2610
- Joined: 02/02/2007 09:23
- Location: mars
#388 Re: Ginekologija i vagine....
s tim da je ova vakcinacija djevojcica pokazla vise negativnog nego pozitivnog, ja sam protiv vakcinacije...Pera Trta wrote:Ovo je zaista jedini način da screening na cervikalni karcinom i borba s njim imaju neki smisao. Sve dok je to na dobrovoljnoj bazi, ništa od toga.Astarot wrote:Da, u sredjenim zemljama je skroz drugacije.Nasa okolina tacnije u Srbiji su usvojili takav zakon, jer po broju incidenci smrtnosti od CeCa Srbija je No1, pa Albanija i Bosna. Da, ukoliko se ne odazoves u nekom odredjenom periodu, slijedi ti kazna.E sad kako ce to u nas biti-Ptice znaju.Bitno je da se odazove, jer bez pregleda nema nista. a licno znam i nagledao sam se preparata i operacija djevojaka koje su bile u kasnoj fazi raka-25, 26 godina...Katastrofa.
U UK je druga situacija-oni su pokrenuli kampanju prevencije-vakcinacija djevojcica 12-13 god i 17-18 god. a rezultati ce se vidjeti tek za 10-15 god. Tako to ide...Da Bog da da i nama drzava obezbijedi takvo sta ;(
ali je i zalosno da sama zena ne misli na sebe i ne ide na preglede...ako ona sama to nece urditi i ne zeli razmisljati o sebi i svom zdravlju e onda je stvarno TUKA
- Loulou
- Posts: 3017
- Joined: 16/04/2008 15:18
#389 Re: Ginekologija i vagine....
semmy wrote:ali je i zalosno da sama zena ne misli na sebe i ne ide na preglede...ako ona sama to nece urditi i ne zeli razmisljati o sebi i svom zdravlju e onda je stvarno TUKA
- semmy
- Posts: 2610
- Joined: 02/02/2007 09:23
- Location: mars
#390 Re: Ginekologija i vagine....
zar nije takoLoulou wrote:semmy wrote:ali je i zalosno da sama zena ne misli na sebe i ne ide na preglede...ako ona sama to nece urditi i ne zeli razmisljati o sebi i svom zdravlju e onda je stvarno TUKA
-
Pera Trta
- Posts: 5420
- Joined: 06/02/2009 00:20
- Location: Zabela kod Požarevca,rodnog mesta predsednika,njegova je zadužbina i njegova verna slika.
#391 Re: Ginekologija i vagine....
uglavnomsemmy wrote:zar nije takoLoulou wrote:semmy wrote:ali je i zalosno da sama zena ne misli na sebe i ne ide na preglede...ako ona sama to nece urditi i ne zeli razmisljati o sebi i svom zdravlju e onda je stvarno TUKA
-
duboka_misao
- Posts: 4333
- Joined: 30/08/2008 15:08
- Location: malta
#392 Re: Ginekologija i vagine....
problem je sto je lakse rasiriti noge za sex nego na ginekoloskom stolu..to je stid znas.. 
-
Pera Trta
- Posts: 5420
- Joined: 06/02/2009 00:20
- Location: Zabela kod Požarevca,rodnog mesta predsednika,njegova je zadužbina i njegova verna slika.
#393 Re: Ginekologija i vagine....
Zato smo po incidenci karcinoma cerviksa u rangu sa Afganistanom.
- semmy
- Posts: 2610
- Joined: 02/02/2007 09:23
- Location: mars
#394 Re: Ginekologija i vagine....
duboka_misao wrote:problem je sto je lakse rasiriti noge za sex nego na ginekoloskom stolu..to je stid znas..
-
Astarot
- Posts: 21
- Joined: 16/10/2009 10:44
#395 Re: Ginekologija i vagine....
ha ha to je bila prica na par sastanaka koje sam slusao...Al nije istina, u Afganistanu nema da se zena sexa na sve strane i da mijenja muzeve i kite kako joj se cefne.Jedan i to je to...Isto je u Africi npr. Libija, nema preljube u toj mjeri kao u Evropi tj.ni muskarci ne saraju uokolo-jer su oni prenosioci virusa.Tako da manje i provjeren sex-pitaj dragog a gdje si ti ranije meto:) i tako to.Sve u svemu danas je lakse pokazati dojku za mamograf-mada i tu je BiH po statistici katastrofalan, nego rasiriti noge kod ginekologa.A da ne spominjem da te ubode dr, u rame injekcijom.Katastrofa ;(Pera Trta wrote:Zato smo po incidenci karcinoma cerviksa u rangu sa Afganistanom.
-
Astarot
- Posts: 21
- Joined: 16/10/2009 10:44
#396 Re: Ginekologija i vagine....
FDA approves Cervarix, GlaxoSmithKline's cervical cancer vaccine Tuesday, 20 October 2009
GlaxoSmithKline (GSK) announced that the U.S. Food and Drug Administration (FDA) has approved CERVARIX® [Human papillomavirus bivalent (types 16 and 18) vaccine, recombinant] for the prevention of cervical pre-cancers and cervical cancer associated with oncogenic human papillomavirus (HPV) types 16 and 18 for use in klix and young women (aged 10-25).
"The approval of Cervarix will bring an important new cervical cancer vaccine to klix and young women," said Deirdre Connelly, President, North American Pharmaceuticals, GlaxoSmithKline. "Immunisation with a vaccine such as CERVARIX - along with annual doctor visits and Pap tests - will help protect women from cervical cancer, the second leading cause of cancer death in women in their twenties and thirties."
CERVARIX was shown to be 93 percent efficacious in the prevention of cervical pre-cancers (cervical intraepithelial neoplasia 2+/ CIN 2+ or adenocarcinoma in situ) associated with HPV 16 or 18, in women without evidence of current infection with, or prior exposure to, the same HPV type at the time of vaccination. The majority (approximately 75 percent) of cervical cancers in North America are caused by HPV types 16 and 18.
The impact of CERVARIX against the overall burden of HPV-related cervical disease results from a combination of efficacy against, and disease contribution of, HPV-16, HPV-18, and oncogenic HPV types not included in the vaccine. In a subgroup of clinical trial participants without oncogenic HPV infection at the time of the first vaccination and without evidence of prior exposure to HPV 16 and 18, the vaccine showed an overall efficacy of 70 percent against pre-cancerous lesions, regardless of HPV type. In an additional analysis that assessed the impact of CERVARIX against specific HPV types not included in the vaccine, in women without oncogenic HPV infection with a specific type at the time of vaccination, approximately 89 percent efficacy was observed in the prevention of precancerous lesions associated with HPV type 31, the third most common cancer-causing virus type in North America.
CERVARIX does not protect against disease caused by all HPV types. Approximately 100 types of HPV have been identified to date and, of these, approximately 15 virus types are known to cause cervical cancer.
"The FDA approval of a vaccine, such as CERVARIX, is an important development in the prevention of cervical cancer," said Levi Downs, M.D., M.S., F.A.C.O.G., assistant professor in the Department of Obstetrics, Gynecology and Women's Health, University of Minnesota, a clinical trial investigator and consultant for GSK. "The treatment of cervical pre-cancers and cancer can be devastating for women and their families. It's important for a vaccine to help reduce the need for the invasive procedures often used to treat cervical pre-cancers and cancers."
CERVARIX has a clinically acceptable safety profile. The most common local adverse reactions and general adverse events in ≥20% of clinical trial participants were pain, redness and swelling at the injection site, fatigue, headache, joint and muscle aching, and gastrointestinal symptoms.
The FDA's approval of CERVARIX was based on data from clinical trials in more than 30 countries involving a diverse population of nearly 30,000 klix and young women receiving CERVARIX.
CERVARIXis expected to be commercially available in the U.S. in late 2009.
About CERVARIX®
CERVARIX is administered to young women between the ages of 10-25 in a three dose schedule that should be completed within six months of the initial dose. To date, CERVARIX has been approved in 100 countries around the world, including the 27 member states of the European Union (EU), Australia, Brazil, South Korea, Mexico and Taiwan. GSK also received World Health Organization (WHO) prequalification in July 2009.
CERVARIX® (Human papillomavirus bivalent (types 16 and 18) vaccine, recombinant) is a registered trademark of the GlaxoSmithKline group of companies.
About Cervical Cancer
Women are at risk of HPV infection and cervical cancer throughout their lives. Approximately 100 types of HPV have been identified to date and, of these, approximately 15 virus types are known to cause cervical cancer. While the majority of cervical cancers in North America are caused by HPV types 16 and 18, approximately 25 percent of all cervical cancers are caused by other oncogenic HPV types. Infection with cancer-causing virus types can lead to abnormal Pap tests, cervical pre-cancers and cervical cancer.
Cervical cancer is the second leading cause of cancer death in women in their twenties and thirties. The American Cancer Society estimates that in 2009, in the U.S. approximately 11,000 women will be diagnosed with cervical cancer and 4,000 women will die from the disease, regardless of age. Worldwide, more than 500,000 women will be newly diagnosed with cervical cancer and 280,000 women will die from it each year.
GlaxoSmithKline (GSK) announced that the U.S. Food and Drug Administration (FDA) has approved CERVARIX® [Human papillomavirus bivalent (types 16 and 18) vaccine, recombinant] for the prevention of cervical pre-cancers and cervical cancer associated with oncogenic human papillomavirus (HPV) types 16 and 18 for use in klix and young women (aged 10-25).
"The approval of Cervarix will bring an important new cervical cancer vaccine to klix and young women," said Deirdre Connelly, President, North American Pharmaceuticals, GlaxoSmithKline. "Immunisation with a vaccine such as CERVARIX - along with annual doctor visits and Pap tests - will help protect women from cervical cancer, the second leading cause of cancer death in women in their twenties and thirties."
CERVARIX was shown to be 93 percent efficacious in the prevention of cervical pre-cancers (cervical intraepithelial neoplasia 2+/ CIN 2+ or adenocarcinoma in situ) associated with HPV 16 or 18, in women without evidence of current infection with, or prior exposure to, the same HPV type at the time of vaccination. The majority (approximately 75 percent) of cervical cancers in North America are caused by HPV types 16 and 18.
The impact of CERVARIX against the overall burden of HPV-related cervical disease results from a combination of efficacy against, and disease contribution of, HPV-16, HPV-18, and oncogenic HPV types not included in the vaccine. In a subgroup of clinical trial participants without oncogenic HPV infection at the time of the first vaccination and without evidence of prior exposure to HPV 16 and 18, the vaccine showed an overall efficacy of 70 percent against pre-cancerous lesions, regardless of HPV type. In an additional analysis that assessed the impact of CERVARIX against specific HPV types not included in the vaccine, in women without oncogenic HPV infection with a specific type at the time of vaccination, approximately 89 percent efficacy was observed in the prevention of precancerous lesions associated with HPV type 31, the third most common cancer-causing virus type in North America.
CERVARIX does not protect against disease caused by all HPV types. Approximately 100 types of HPV have been identified to date and, of these, approximately 15 virus types are known to cause cervical cancer.
"The FDA approval of a vaccine, such as CERVARIX, is an important development in the prevention of cervical cancer," said Levi Downs, M.D., M.S., F.A.C.O.G., assistant professor in the Department of Obstetrics, Gynecology and Women's Health, University of Minnesota, a clinical trial investigator and consultant for GSK. "The treatment of cervical pre-cancers and cancer can be devastating for women and their families. It's important for a vaccine to help reduce the need for the invasive procedures often used to treat cervical pre-cancers and cancers."
CERVARIX has a clinically acceptable safety profile. The most common local adverse reactions and general adverse events in ≥20% of clinical trial participants were pain, redness and swelling at the injection site, fatigue, headache, joint and muscle aching, and gastrointestinal symptoms.
The FDA's approval of CERVARIX was based on data from clinical trials in more than 30 countries involving a diverse population of nearly 30,000 klix and young women receiving CERVARIX.
CERVARIXis expected to be commercially available in the U.S. in late 2009.
About CERVARIX®
CERVARIX is administered to young women between the ages of 10-25 in a three dose schedule that should be completed within six months of the initial dose. To date, CERVARIX has been approved in 100 countries around the world, including the 27 member states of the European Union (EU), Australia, Brazil, South Korea, Mexico and Taiwan. GSK also received World Health Organization (WHO) prequalification in July 2009.
CERVARIX® (Human papillomavirus bivalent (types 16 and 18) vaccine, recombinant) is a registered trademark of the GlaxoSmithKline group of companies.
About Cervical Cancer
Women are at risk of HPV infection and cervical cancer throughout their lives. Approximately 100 types of HPV have been identified to date and, of these, approximately 15 virus types are known to cause cervical cancer. While the majority of cervical cancers in North America are caused by HPV types 16 and 18, approximately 25 percent of all cervical cancers are caused by other oncogenic HPV types. Infection with cancer-causing virus types can lead to abnormal Pap tests, cervical pre-cancers and cervical cancer.
Cervical cancer is the second leading cause of cancer death in women in their twenties and thirties. The American Cancer Society estimates that in 2009, in the U.S. approximately 11,000 women will be diagnosed with cervical cancer and 4,000 women will die from the disease, regardless of age. Worldwide, more than 500,000 women will be newly diagnosed with cervical cancer and 280,000 women will die from it each year.
- Šeherzada
- Posts: 7054
- Joined: 10/08/2006 00:01
- Location: Pod ovom kapom nebeskom i mojom dusom Bosanskom....
#397 Re: Ginekologija i vagine....
J abih preporucila svakoj od vas koja moze da nabavi iz Srbije vaginalete MUMIE ,i iz Hrvatske ACIDOSALUS.Oboje su biljne ,ne skode a lijece sve upale,ciste ,cin-ove itd.Uglavnom ja sam stavila jednu kutiju jednih nakon 3 mj drugih i otisla na papu koji je bio cist kao suza.Jesu skupe ali su zato odlicne!
- anastasija
- Posts: 249
- Joined: 20/10/2009 01:49
#398 Re: Ginekologija i vagine....
Bogami skupo kod vas ti pregledi i to. Ja plaam oko 50 eura, znaci oko 100 maraka to izadje.
- tech10
- Posts: 15328
- Joined: 14/09/2005 14:04
#399 Re: Ginekologija i vagine....
I sta bi sa kutijom?Šeherzada wrote:.Uglavnom ja sam stavila jednu kutiju jednih nakon 3 mj drugih i otisla na papu koji je bio cist kao suza.Jesu skupe ali su zato odlicne!
- Šeherzada
- Posts: 7054
- Joined: 10/08/2006 00:01
- Location: Pod ovom kapom nebeskom i mojom dusom Bosanskom....
#400 Re: Ginekologija i vagine....
Kutiju bacila,a ono iz kutije stavila gdje mu je mjestotech10 wrote:I sta bi sa kutijom?Šeherzada wrote:.Uglavnom ja sam stavila jednu kutiju jednih nakon 3 mj drugih i otisla na papu koji je bio cist kao suza.Jesu skupe ali su zato odlicne!
